Five RSV Articles for the Week
FDA panel favors approval for two RSV vaccines, 'Tripledemic' hits US households, and a monoclonal antibody may be ready for next season—here are five RSV stories you should check out this week.
FDA panel favors approval for two RSV vaccines, 'Tripledemic' hits US households, and a monoclonal antibody may be ready for next season—here are five RSV stories you should check out this week.
GlaxoSmithKline has issued two grants totaling $380,000 to the American Thoracic Society's COVID-19 Crisis Fund.
GlaxoSmithKline and Theravance have completed enrollment of 16,000 patients for SUMMIT, a study to determine the impact of GSK's Breo Ellipta on all cause mortality amongst patients with moderate COPD and cardiovascular disease.